Key Points:
·Agent Authorization: Canadian cannabis distributor FTLD has been granted full authority to oversee the sales of CCELL products in the Canadian and international markets.
·Product coverage includes pod, disposable equipment, and core categories such as batteries.
·Technology collaboration: The two parties plan to work together to promote the market for vaporized cannabis equipment.
·Market positioning: Targeting the North American and global compliant cannabis markets.
According to a report from the Associated Press on June 23rd, Canadian vaporizer hardware distributor Follow The Leader Distribution Company Ltd. (FTLD) has announced that it has been authorized by Smoore Technology's brand CCELL to become its official distributor in Canada and some international markets.
According to the authorized agreement, FTLD will distribute core products of CCELL, including pods, disposable devices, and batteries. CCELL is a cannabis vaporization device technology brand under Smoore, and its ceramic heating technology has a high market share in the North American cannabis vaporization market.
The headquarters of FTLD is located in Vancouver, where they primarily provide customized atomization hardware and OEM services to the North American and international markets. The company's product line, ASCERA, is tailored towards plant extract atomization scenarios, with an emphasis on equipment compatibility with oil viscosity and thermal stability.
FTLD stated that the collaboration will expand its product coverage in the Canadian market, and plans to further engage in joint development projects with CCELL.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
